Human Cytomegalovirus Infection Suppresses CD34

hematopoiesis hematopoietic stem cell transplant human cytomegalovirus humanized mice myelosuppression progenitor cell

Journal

Microorganisms
ISSN: 2076-2607
Titre abrégé: Microorganisms
Pays: Switzerland
ID NLM: 101625893

Informations de publication

Date de publication:
06 Apr 2020
Historique:
received: 10 03 2020
revised: 03 04 2020
accepted: 04 04 2020
entrez: 10 4 2020
pubmed: 10 4 2020
medline: 10 4 2020
Statut: epublish

Résumé

Human cytomegalovirus (HCMV) infection is a serious complication in hematopoietic stem cell transplant (HSCT) recipients due to virus-induced myelosuppression and impairment of stem cell engraftment. Despite the clear clinical link between myelosuppression and HCMV infection, little is known about the mechanism(s) by which the virus inhibits normal hematopoiesis because of the strict species specificity and the lack of surrogate animal models. In this study, we developed a novel humanized mouse model system that recapitulates the HCMV-mediated engraftment failure after hematopoietic cell transplantation. We observed significant alterations in the hematopoietic populations in peripheral lymphoid tissues following engraftment of a subset of HCMV

Identifiants

pubmed: 32268565
pii: microorganisms8040525
doi: 10.3390/microorganisms8040525
pmc: PMC7232458
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : NIH HHS
ID : P01 A127335
Pays : United States

Références

mBio. 2018 Apr 24;9(2):
pubmed: 29691342
Clin Exp Immunol. 2013 Dec;174(3):372-88
pubmed: 23869841
Blood. 2008 Oct 1;112(7):2979-89
pubmed: 18587012
Nat Biotechnol. 2019 Oct;37(10):1163-1173
pubmed: 31451733
Annu Rev Virol. 2016 Sep 29;3(1):333-357
pubmed: 27501258
Blood. 1995 Dec 1;86(11):4086-90
pubmed: 7492764
Biol Blood Marrow Transplant. 2011 Sep;17(9):1362-74
pubmed: 21277377
Am J Transplant. 2013 Oct;13(10):2601-10
pubmed: 23919557
J Virol. 1999 Jun;73(6):4806-12
pubmed: 10233941
Ann Hematol. 1992 Jun;64 Suppl:A128-31
pubmed: 1322182
J Infect Dis. 1989 Jan;159(1):127-30
pubmed: 2535865
Blood. 1991 Aug 1;78(3):844-8
pubmed: 1650265
Proc Natl Acad Sci U S A. 2002 Dec 10;99(25):16255-60
pubmed: 12456880
Blood. 2004 Aug 1;104(3):687-95
pubmed: 15090458
J Gen Virol. 1996 Dec;77 ( Pt 12):3099-102
pubmed: 9000102
Blood. 1990 May 15;75(10):1965-73
pubmed: 1692491
J Virol. 2007 Mar;81(5):2095-101
pubmed: 16956936
J Clin Oncol. 2000 Feb;18(3):537-46
pubmed: 10653869
Blood. 1996 Dec 15;88(12):4526-33
pubmed: 8977244
Cell Host Microbe. 2020 Jan 8;27(1):104-114.e4
pubmed: 31866424
Blood. 1992 Jul 1;80(1):170-8
pubmed: 1377049
Biol Blood Marrow Transplant. 2003 Jan;9(1):52-9
pubmed: 12533742
J Clin Invest. 2011 May;121(5):1673-80
pubmed: 21659716
Sci Rep. 2017 Apr 20;7(1):937
pubmed: 28428537
Blood. 2000 Jun 15;95(12):3702-9
pubmed: 10845900
mBio. 2019 Aug 20;10(4):
pubmed: 31431555
Cell Host Microbe. 2010 Sep 16;8(3):284-91
pubmed: 20833379

Auteurs

Lindsey B Crawford (LB)

Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR 97006, USA.

Rebecca Tempel (R)

Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR 97006, USA.

Daniel N Streblow (DN)

Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR 97006, USA.

Andrew D Yurochko (AD)

Department of Microbiology and Immunology, Louisiana State University Health Sciences Center, Shreveport, LA 71130, USA.

Felicia D Goodrum (FD)

Department of Immunobiology, BIO5 Institute, University of Arizona, Tucson, AZ 85719, USA.

Jay A Nelson (JA)

Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR 97006, USA.

Patrizia Caposio (P)

Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR 97006, USA.

Classifications MeSH